A modified caprylic acid method for manufacturing immunoglobulin G from human plasma with high yield and efficient virus clearance

Vox Sanguinis

Volumn 90, Issue 2, 2006, Pages 97-104

  Parkkinen, J ^a   Rahola, A ^a   Von Bonsdorff, L ^a   Tolo H ^a   Torma E ^a  

^a FINNISH RED CROSS BLOOD SERVICE   (Finland)

Author keywords

Caprylic acid; IgG; Intravenous immunoglobulin; Nanofiltration; Parvovirus; Polyethylene glycol

Indexed keywords

IMMUNOGLOBULIN G; MACROGOL; OCTANOIC ACID;

ANALYTIC METHOD; ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; BOVINE DIARRHEA VIRUS; CATTLE DISEASE; CELL FRACTIONATION; HUMAN; IMMUNOGLOBULIN PRODUCTION; NANOFILTRATION; NONHUMAN; PARVOVIRUS; PHYSICAL CHEMISTRY; POLYMERASE CHAIN REACTION; PRECIPITATION; PRIORITY JOURNAL; PRODUCT RECOVERY; PROTEIN PURIFICATION; PROTEIN STABILITY; ULTRAFILTRATION; VIRUS INFECTIVITY; VIRUS RESISTANCE;

ANIMALS; CATTLE; CHROMATOGRAPHY, ION EXCHANGE; DIARRHEA VIRUSES, BOVINE VIRAL; DRUG STABILITY; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; NANOTECHNOLOGY; OCTANOIC ACIDS; PARVOVIRUS B19, HUMAN; POLYETHYLENE GLYCOLS; PRECIPITATION; ULTRAFILTRATION;

EID: 33644931642     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2005.00731.x     Document Type: Article

References (37)

1. Buckley RH Schiff RI The use of intravenous immune globulin in immunodeficiency diseases N Engl J Med 1991 325 110 117
2. Kazatchkine MD Kaveri SV Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin N Engl J Med 2001 345 747 755
3. Knezevic-Maramica I Kruskall MS Intravenous immune globulins: an update for clinicians Transfusion 2003 43 1460 1480
4. Cohn EJ Strong LE Hughes WL Jr. Mulford DJ Ashworth JN Melin M Taylor HL Preparation and properties of serum and plasma proteins III. A system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids J Am Chem Soc 1946 68 459 475
5. Oncley JL Melin M Richert DA Cameron JW Gross PM Jr. The separation of the antibodies, isoagglutinins, prothrombin, plasminogen and beta-lipoprotein into subfractions of human plasma J Am Chem Soc 1949 71 541 550
6. Barandun S Kistler P Jeunet F Isliker H Intravenous administration of human gamma globulin Vox Sang 1962 7 157 174
7. Romer J Spath PJ Skvaril F Nydegger UE Characterization of various immunoglobulin preparations for intravenous application. II. Complement activation and binding to staphylococcus protein A Vox Sang 1982 42 74 80
8. Lane RS Non-A, non-B hepatitis from intravenous immunoglobulin Lancet 1983 ii 974 975
9. Lever AM Webster AD Brown D Thomas HC Non-A, non-B hepatitis occurring in agammaglobulinaemic patients after intravenous immunoglobulin Lancet 1984 ii 1062 1064
10. Bjoro K Froland SS Yun Z Samdal HH Haaland T Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin N Engl J Med 1994 331 1607 1611
11. Lebing W Remington KM Schreiner C Paul HI Properties of a new intravenous immunoglobulin (IGIV-C, 10%) produced by virus inactivation with caprylate and column chromatography Vox Sang 2003 84 193 201
12. Prowse C Ludlam CA Yap PL Human parvovirus B19 and blood products Vox Sang 1997 72 1 10
13. Young NS Parvovirus infection and its treatment Clin Exp Immunol 1996 104 26 30
14. Hayakawa F Imada K Towatari M Saito H Life-threatening human parvovirus B19 infection transmitted by intravenous immune globulin Br J Haematol 2002 118 1187 1189
15. Erdman DD Anderson BC Török TJ Finkel TH Anderson LJ Possible transmission of parvovirus B19 from intravenous immune globulin J Med Virol 1997 53 233 236
16. Burnouf Radosevich M Nanofiltration of plasma-derived biopharmaceutical products Haemophilia 2003 9 24 37
17. Hirvonen M Koskinen S Tölö H A sensitive enzyme immunoassay for the measurement of low concentrations of IgA J Immunol Methods 1993 163 59 65
18. European Pharmacopoeia 5th edn
19. Skoog B Determination of polyethylene glycols 4000 and 6000 in plasma protein preparations Vox Sang 1979 37 345 349
20. Terpstra FG Parkkinen J Tölö H Koenderman AHL ter Hart HGJ von Bonsdorff L Törmä E van Engelenburg FAC Viral safety of Nanogam®, a new 15 nm-filtered liquid immunoglobulin product Vox Sang 2006 90 21 32
21. Steinbuch M Audran R The isolation of IgG from mammalian sera with the aid of caprylic acid Arch Biochem Biophys 1969 134 279 284
22. Lundblad JL Seng RL Inactivation of lipid-enveloped viruses in proteins by caprylate Vox Sang 1991 60 75 81
23. Dichtelmüller H Rudnick D Kloft M Inactivation of lipid enveloped viruses by octanoic acid treatment of immunoglobulin solution Biologicals 2002 30 135 142
24. Korneyeva M Hotta J Lebing W Rosenthal RS Franks L Petteway SR Jr. Enveloped virus inactivation by caprylate: a robust alternative to solvent-detergent treatment in plasma derived intermediates Biologicals 2002 30 153 162
25. Eibl MM Cairns L Rosen FS Safety and efficacy of a monomeric, functionally intact intravenous IgG preparation in patients with primary immunodeficiency syndromes Clin Immunol Immunopathol 1984 31 151 160
26. Uemura Y Uriyu K Hirao Y Takechi K Ishikawa H Nakajima T Kagitani Y Yokoyama K Funakoshi S Nishida M Inactivation and elimination of viruses during the fractionation of an intravenous immunoglobulin preparation: liquid heat treatment and polyethylene glycol fractionation Vox Sang 1989 56 155 161
27. Hirasaki T Ishikawa G Nakano H Manabe S-I Yamamoto N Mechanism of virus removal by regenerated cellulose hollow fiber (BMMTM) Membrane 1995 20 135 142
28. Zav'yalov V Troitsky GV Demchenko AP Generalov IV Temperature and pH dependent changes of immunoglobulin G structure Biochem Biophys Acta 1975 386 155 167
29. Calmettes P Cser L Rajnavolgyi E Temperature and pH dependence of immunoglobulin G conformation Arch Biochem Biophys 1991 291 277 283
30. Omar A Kempf C Removal of neutralized model parvoviruses and enteroviruses in human IgG solutions by nanofiltration Transfusion 2002 42 1005 1010
31. Schmidt I Blümel J Seitz H Willkommen H Löwen J Parvovirus B19 DNA in plasma pools and plasma derivatives Vox Sang 2001 81 228 235
32. Reichl HE Foster PR Welch AG Li Q MacGregor IR Somerville RA Fernie K Steele PJ Taylor DM Studies on the removal of a bovine spongiform encephalopathy-derived agent by processes used in the manufacture of human immunoglobulin Vox Sang 2002 83 137 145
33. Lee DC Stenland CJ Hartwell RC Ford EK Cai K Miller JL Gilligan KJ Rubenstein R Fournel M Petteway SR Jr. Monitoring plasma processing steps with a sensitive Western blot assay for the detection of the prion protein J Virol Methods 2000 84 77 89
34. Trejo R Hotta JA Lebing W Stenland C Storms RE Lee DC Li H Petteway S Jr. Remington KM Evaluation of virus and prion reduction in a new intravenous immunoglobulin manufacturing process Vox Sang 2003 84 176 187
35. Xie G Timasheff SN The thermodynamic mechanism of protein stabilization by trehalose Biophys Chem 1997 64 25 43
36. Tatford OO Gomme PT Bertolini J Analytical techniques for the evaluation of liquid protein therapeutics Biotechnol Appl Biochem 2004 40 67 81
37. Diemel RV ter Hart H Derksen GJA Koenderman A Aalberse R Characterization of immunoglobulin G fragments in liquid intravenous immunoglobulin products Transfusion 2005 45 1601 1609